Journal
IMMUNE NETWORK
Volume 20, Issue 5, Pages -Publisher
KOREA ASSOC IMMUNOLOGISTS
DOI: 10.4110/in.2020.20.e41
Keywords
SARS coronavirus 2; Spike glycoprotein; COVID-19 receptor binding domain; COVID-19 mutation; COVID-19 antigens
Categories
Funding
- BK21 plus project fund
- National Research Foundation of Korea [NRF-2015R1A2A2A01003472, NRF-2014M3A6A4075058, NRF2015R1A2A1A15051472]
- Konkuk University
- Rural Development Administration, Republic of Korea [PJ013284012020]
- [NRF-2019R1I1A1A01057699]
Ask authors/readers for more resources
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is a positive-sense single-stranded RNA (+ssRNA) that causes coronavirus disease 2019 (COVID-19). The viral genome encodes twelve genes for viral replication and infection. The third open reading frame is the spike (S) gene that encodes for the spike glycoprotein interacting with specific cell surface receptor - angiotensin converting enzyme 2 (ACE2) - on the host cell membrane. Most recent studies identified a single point mutation in S gene. A single point mutation in Sgene leading to an amino acid substitution at codon 614 from an aspartic acid 614 into glycine (D614G) resulted in greater infectivity compared to the wild type SARS-CoV2. We were interested in investigating the mutation region of Sgene of SARS-CoV2 from Korean COVID-19 patients. New mutation sites were found in the critical receptor binding domain (RED) of Sgene, which is adjacent to the aforementioned D614G mutation residue. This specific sequence data demonstrated the active progression of SARS-CoV2 by mutations in the RED of Sgene. The sequence information of new mutations is critical to the development of recombinant SARS-CoV2 spike antigens, which may be required to improve and advance the strategy against a wide range of possible SARS-CoV2 mutations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available